BlossomHill Therapeutics Inc.
BLSM | NASDAQ
$27.06
+$0.26 (+0.97%)
Sep 22, 2026, 10:45 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 |
|---|---|---|
Net Income | -60.56M | -30.7M |
Depreciation & Amortization | 441K | 350K |
Stock-Based Compensation | 1.09M | 504K |
Other Working Capital | 9.35M | -1.13M |
Other Non-Cash Items | 1.29M | 697K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | 10.81M | -2.27M |
Operating Cash Flow | -46.93M | -31.42M |
Capital Expenditures | -1.07M | -92K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -1.07M | -92K |
Debt Repayment | n/a | n/a |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 589K | 420K |
Financial Cash Flow | 84.53M | 17.56M |
Net Cash Flow | 36.54M | -13.95M |
Free Cash Flow | -47.99M | -31.51M |
Adj. Free Cash Flow | -49.08M | -32.01M |
Maintenance CapEx | -441K | -92K |
Growth CapEx | -626K | n/a |
Owner Earnings | -47.37M | -31.51M |
Add to Watchlist
Select watchlists to add or remove BLSM